SIRT1激活剂
| 英文名 | SRT1720 | CAS号 | 1001645-58-4 |
| 试剂别名 |
N-(2-(3-(piperazin-1-ylMethyl)iMidazo[2,1-b]thiazol-6-yl)phenyl)quinoxaline-2-carboxaMide hydrochloride;SRT1720;N-[2-[3-(1-piperazinylmethyl)imidazo[2,1-b]thiazol-6-yl]phenyl]-2-Quinoxalinecarboxamide;N-[2-[3-(1-Piperazinylmethyl)imidazo[2,1-b]thiazol-6-yl]phenyl]-2-quinoxalinecarboxamide hydrochloride;N-[2-[3-(piperazin-1-ylmethyl)imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]quinoxaline-2-carboxamide,hydrochloride;SRT 1720 Hydrochloride;SRT-1720;SRT1720 HCl;SRT1720 Hydrochlorid;CS-0509;QCR-61;SRT-1720,SRT 1720;SRT1720HCL;SRT-1720 xhydrochloride;SRT 1720 (Hydrochloride);SRT 1720 tetrahydrochloride;SRT1720 hydrochloride, >=98%;N-(2-(3-(Piperazin-1-ylmethyl)imidazo[2,1-b]thiazol-6-yl)phenyl)quinoxaline-2-carboxamide hydr;N-[2-[3-(1-Piperazinylmethyl)imidazo[2,1-b]thiazol-6-yl]phenyl]-2-quinoxalinecarboxamide hydrochloride SRT 1720
|
分子式 | C25H23N7O.HCl |
| 产品编号 | APEA4180 | 分子量 | 506.02 |
| MDL号 |
| 产品名称： | SIRT1激活剂 |
| 英文名称： | SRT1720 |
| 英文别名： | N-(2-(3-(piperazin-1-ylMethyl)iMidazo[2,1-b]thiazol-6-yl)phenyl)quinoxaline-2-carboxaMide hydrochloride;SRT1720;N-[2-[3-(1-piperazinylmethyl)imidazo[2,1-b]thiazol-6-yl]phenyl]-2-Quinoxalinecarboxamide;N-[2-[3-(1-Piperazinylmethyl)imidazo[2,1-b]thiazol-6-yl]phenyl]-2-quinoxalinecarboxamide hydrochloride;N-[2-[3-(piperazin-1-ylmethyl)imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]quinoxaline-2-carboxamide,hydrochloride;SRT 1720 Hydrochloride;SRT-1720;SRT1720 HCl;SRT1720 Hydrochlorid;CS-0509;QCR-61;SRT-1720,SRT 1720;SRT1720HCL;SRT-1720 xhydrochloride;SRT 1720 (Hydrochloride);SRT 1720 tetrahydrochloride;SRT1720 hydrochloride, >=98%;N-(2-(3-(Piperazin-1-ylmethyl)imidazo[2,1-b]thiazol-6-yl)phenyl)quinoxaline-2-carboxamide hydr;N-[2-[3-(1-Piperazinylmethyl)imidazo[2,1-b]thiazol-6-yl]phenyl]-2-quinoxalinecarboxamide hydrochloride SRT 1720 |
| 中文别名： | SRT-1720 |
| CAS No.： | 1001645-58-4 |
| 分子式： | C25H23N7O.HCL |
| 分子量： | 506.02 |
| 危险品级别： | |
| HS符号： | |
| 危害声明： |
